Tradestie Institutional Equity Comparison Engine

OPTO vs PASW โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PASW Overall Edge

PASW Captures Institutional Edge (2โ€“0 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ping An Biomedical Co., Ltd. Ordinary Shares (PASW) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, OPTO trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus PASW at N/M Forward P/E and -41.3% operating margin (-47.4% YoY). In options structure, OPTO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PASW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
OPTO N/M vs PASW N/M Fwd P/E
Growth & Margin Winner PASW
Op Margin N/A vs -41.3% ยท YoY N/A vs -47.4%
Momentum & Technical Winner PASW
1Y -53.6% vs +95.7% ยท 52W Pos 0% vs 17%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
OPTO US Equity
OPTO
Institutional Equity
$12.11
-12.53% 1D
Market Cap N/A
1M Return -31.8%
1Y Return -53.57%
Forward P/E N/M
Unified AI Score
47.3 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
PASW NASDAQ
Ping An Biomedical Co., Ltd. Ordinary Shares
Institutional Equity
$1.13
-10.32% 1D
Market Cap $3.6M
1M Return +743.28%
1Y Return +95.67%
Forward P/E N/M
Unified AI Score
59.1 / 100 HOLD
Tech 60.0 Fund 47.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OPTO -53.57% PASW +95.67% Spread: +879.8 pp (PASW Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
OPTO TTM Op. Margin: N/A PASW TTM Op. Margin: -41.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OPTO vs PASW. Trailing 12-month operating profitability (OPTO N/A vs PASW -41.3%) and valuation multiples (OPTO N/M vs PASW N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OPTO (1) vs PASW (7)
Institutional Metric OPTO PASW Criterion Row Winner
Market Capitalization Scale N/A $3.6M Larger Scale PASW
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A -47.4% Higher Growth PASW
Operating Margin (TTM) Profitability N/A -41.3% Higher Margin PASW
Net Profit Margin Profitability N/A -14.8% Higher Margin PASW
Return on Equity (ROE) Capital Efficiency N/A -11.3% Higher ROE PASW
52-Week Range Position Momentum 0% ($12โ€“$26) 17% ($0โ€“$6) Stronger Trend PASW
Beta / 30D Volatility Risk Regime 3.64ฮฒ ยท 108% Vol -10.07ฮฒ ยท 11691% Vol Lower Realized Risk OPTO
Unified Institutional Score Composite Signal 47.3 / 100 (HOLD) 59.1 / 100 (HOLD) Higher Composite PASW

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OPTO vs PASW Buy Guide
OPTO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OPTO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PASW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PASW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OPTO nor PASW registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.